Appointment of M/s. KP & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2026-27
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeevan Scientific Technology Limited reported strong FY2025-26 results. Standalone revenue grew 23.7% to Rs.5,393.13 lakhs while consolidated revenue increased 31.4% to Rs.6,153.71 lakhs. Standalone PAT jumped 124% to Rs.165.01 lakhs and consolidated PAT rose significantly to Rs.103.33 lakhs from just Rs.5.90 lakhs. The company also allotted 1,61,250 equity shares under the ESOP scheme (exercise price Rs.10 per share, money realized Rs.16.12 lakhs), taking total share capital to Rs.20.08 crore. Additionally, 4,80,000 new stock options were granted to eligible employees. M/s. KP & Associates was appointed as internal auditors for FY 2026-27. Statutory auditors M/s. Pavuluri & Co. issued unmodified opinions on both standalone and consolidated financials. The company also invested Rs.300 lakhs in associate Naya Pharma Private Limited during the year.
Strong revenue and profit growth demonstrates operational strength. ESOP issuance and new auditor appointment indicate governance updates. The Rs.300 lakh investment in associate company represents a related party transaction requiring shareholder attention.